Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

10 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Calcinosis in systemic sclerosis.
Pokeerbux MR, Farhat MM, Merger M, Launay D, Hachulla E. Pokeerbux MR, et al. Joint Bone Spine. 2021 Jul;88(4):105180. doi: 10.1016/j.jbspin.2021.105180. Epub 2021 Mar 31. Joint Bone Spine. 2021. PMID: 33812021 No abstract available.
[GATA2 gene mutations: 3 cases].
Perrard N, Pokeerbux MR, Quesnel B, Duployez N, Fenwarth L, Preudhomme C, Lefèvre G, Baillet C, Launay D, Terriou L. Perrard N, et al. Among authors: pokeerbux mr. Rev Med Interne. 2022 Nov;43(11):677-682. doi: 10.1016/j.revmed.2022.08.007. Epub 2022 Aug 28. Rev Med Interne. 2022. PMID: 36041908 French.
National early warning score to predict intensive care unit transfer and mortality in COVID-19 in a French cohort.
Pokeerbux MR, Yelnik CM, Faure E, Drumez E, Bruandet A, Labreuche J, Assaf A, Goffard A, Garabedian C, Poissy J, Desbordes J, Garrigue D, Scherpereel A, Faure K, Lambert M; Lille Covid-team. Pokeerbux MR, et al. Int J Clin Pract. 2021 Jun;75(6):e14121. doi: 10.1111/ijcp.14121. Epub 2021 Mar 9. Int J Clin Pract. 2021. PMID: 33650136 Free PMC article.
Effect of weight-adjusted intermediate-dose versus fixed-dose prophylactic anticoagulation with low-molecular-weight heparin on venous thromboembolism among noncritically and critically ill patients with COVID-19: the COVI-DOSE trial, a multicenter, randomised, open-label, phase 4 trial.
Zuily S, Lefèvre B, Sanchez O, Empis de Vendin O, de Ciancio G, Arlet JB, Khider L, Terriat B, Greigert H, Robert CS, Louis G, Trinh-Duc A, Rispal P, Accassat S, Thiery G, Montani D, Azarian R, Meneveau N, Soudet S, Le Mao R, Maurier F, Le Moing V, Quéré I, Yelnik CM, Lefebvre N, Martinot M, Delrue M, Benhamou Y, Parent F, Roy PM, Presles E, Goehringer F, Mismetti P, Bertoletti L, Rossignol P, Couturaud F, Wahl D, Thilly N, Laporte S; COVI-DOSE investigators. Zuily S, et al. EClinicalMedicine. 2023 Jun;60:102031. doi: 10.1016/j.eclinm.2023.102031. Epub 2023 Jun 9. EClinicalMedicine. 2023. PMID: 37350990 Free PMC article.